Skip to search formSkip to main contentSkip to account menu

Parkinson Disease 13

Known as: PARK13 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Deletion at 22q11.2 responsible for Di George syndrome (DGs) is a risk factor for early-onset Parkinson's disease (EOPD). To date… 
2017
2017
Background. HTRA2 has already been nominated as PARK13 which may cause Parkinson's disease, though there are still discrepancies… 
Review
2017
Review
2017
High-temperature-requirement A2 (HtrA2)/Omi/PARK13 is a serine protease with extensive homology to the Escherichia coli HtrAs… 
2016
2016
Although mutations in the leucine‐rich repeat kinase 2 (LRRK2) gene are the most common cause of genetic Parkinson's disease… 
2015
2015
Mutations in HTRA2/Omi/PARK13 have been associated with Parkinson's disease (PD) and PARK13 show neuroprotective properties in… 
2014
2014
Background: Mutations in PARK13 have been implicated in Parkinson disease. Results: AtPARK13 confers thermotolerance in… 
Highly Cited
2007
Highly Cited
2007
In mice, targeted deletion of the serine protease HtrA2 (also known as Omi) causes mitochondrial dysfunction leading to a… 
2007
2007
Intensive Forschung innerhalb des letzten Jahrzehnts hat die Rolle genetischer Veranderungen bei der Entstehung des…